Automation of laboratory tests, bioinformatic analysis of biological sequences, and professional data management are used routinely in a modern university hospital-based infectious diseases institute. This dates back to at least the 1980s. However, the scientific methods of this 21st century are changing with the increased power and speed of computers, with the "big data" revolution having already happened in genomics and environment, and eventually arriving in medical informatics. The research will be increasingly "data driven, " and the powerful machine learning methods whose efficiency is demonstrated in daily life will also revolutionize medical research. A university-based institute of infectious diseases must therefore not only gather excellent computer scientists and statisticians (as in the past, and as in any medical discipline), but also fully integrate the biologists and clinicians with these computer scientists, statisticians, and mathematical modelers having a broad culture in machine learning, knowledge representation, and knowledge discovery.
What should be the data science priorities of a competitive "dream" 21st-century university hospital-based research institute on infectious diseases integrating microbiology, clinical care of infectious diseases patients, and reference centers for discovery and classification of new microorganisms, and carrying out epidemiological, clinical, and fundamental research?
The fight against infectious diseases requires a multiplicity of players who use biostatistics, medical informatics, mathematical modeling, and information sciences in general. This concerns, within the hospital, laboratories of microbiology, dedicated clinical infectious wards, and almost all other clinical specialties; and, outside the hospital, system biology, ecology, veterinary science, public health, and even nonmedical disciplines such as sociology and demography. I will not take up space to detail the needs that everybody agrees upon, such as to have engineers to handle the automation of laboratory processes and bioinformaticians to exploit the genomic data. Rather, I will describe some features of the present age of information which, from my point of view, should impact the definition of the data science workforce to implement.
FROM BIG DATA TO MACHINE LEARNING
The internet of things comes among one of the most wellknown trends of "big data"; e-advertising aggregates myriads of pieces of information about our habits, localizations, and internet search queries, all in order to target advertising to us. Booking a room in a large city, taking a taxi, finding one's way when driving is no longer done as it was 10 years ago-one can safely predict that biomedical research, clinical care, and public health will be similarly revolutionized; one can also observe that it has not yet been done.
Indeed, blood specimens of a patient, once analyzed with automated platforms, will provide at a low cost between hundreds and millions of pieces of information if analyzed with techniques such as next-generation sequencing. In the hospital, a patient gets a series of biomedical images that generate gigabytes or terabytes of data. His clinical information is abstracted in an electronic health record. His physical activity is recorded on his mobile phone, and downloaded to servers. The characteristics of his environment are available by mapping the lifeline of his localizations (registered by his smartphone) with public environmental databases that, for example, characterize the land cover around him, with a precision of 200 meters thanks to satellite imaging [1] . These data possess the 3 characteristics of big data: their huge volume, their variety, and the velocity with which they are acquired. This has been referenced as the 3Vs [2] .
At the beginning, the advent of big data in biomedical research was just seen as a change of scale for the biostatisticians-for example, statistical testing of an observed correlation could not be done with the standard 5% level of significance. New statistical methods were designed to limit the false discovery rate due to multiple testing. But it is now clear that, with the new big data technologies rising, a total change of paradigm is occurring: In the past, the research strategy in biomedicine was "hypothesis driven"; it will now become "data driven" [3] .
The tremendous amount of data that we have to face are currently analyzed with "machine learning" methods. Machine learning stands at the intersection of artificial intelligence and statistics. It was increasingly used in the last decade in various domains from games (with the examples of Chess and Go), to speech recognition. There are already some applications of machine learning in infectious diseases-for example, for studying multidrug resistance [4] , or host-pathogen interactions [5] . The machine learning methods can be broadly separated into 2 types: "unsupervised" and "supervised. " In unsupervised methods, the goal is to identify objectively "different" groups of "similar" objects; for example, clusters of patients in an n-dimensional space, or clusters of microorganisms. The hierarchical classifications (which are represented by trees and dendrograms) are another kind of unsupervised method widely used by bioinformaticians to produce phylogenies of sequences. These unsupervised methods have many variants (in cluster analysis, biostatisticians can set a priori the maximum number of clusters they want to identify; classification trees can be built top down or bottom up, etc). Here, defining a good distance between the items under study (eg, DNA sequences or patients defined by a clinical profile) is critical, and unfortunately is in general done arbitrarily. The second category of methods (supervised classification) is used when the goal is to predict a variable of interest (eg, dead from sepsis/ survived) from the set of (big) data available.
There are a dozen different algorithms for machine learning, but regardless of the specific method used, the interaction between biostatisticians and the biomedical community will be deeply changed. Take the example of the prognosis of patients in intensive care. In the past (and still now), logistic multiple regression was the classical method used to derive a prognosis score and identify the predictors among a set of bioclinical variables of interest and of possibly confounding variables (eg, severity score, social variables). The output of the model was easily understood by the clinician (eg, he or she could find that one variable remained predictive, even after controlling for all other variables, because its coefficient in the regression equation was significantly different from zero). By contrast, machine learning methods are in general black boxes, and the clinician will ignore which variables are used to make the prediction. He will know that "it works, " not how it works. These complicated empirical predictive models can be judged only on their performance. This is why developing quality validation methods of predictive models has become an essential part of the work of statisticians, and constitutes an important body of mathematical work. The key principle to assess the quality of a prediction is to generate the predictive model using a first set of objects (the "training" sample) and test it on a second, independent sample (the "validation sample"). Special methods, such as cross-validation, have been devised for the frequent situations where the number of available samples is too small to permit splitting the study population into training and validation subsets. This article does not have the ambition to review the innumerable methodological problems posed in the analysis of big data, and the details above were given only to convince the reader that the biostatisticians needed by the hypothetical institute of infectious disease must (1) be scientists aware of the rapid development of new methods of analysis, and (2) be fully integrated in the institute because the choice of the best methods for a given problem requires an in-depth understanding of the data.
Reproducible Research
For big data analysis using cryptic algorithms of machine learning, as well as for the most classical biostatistics methods, an already important medical research trend is the call for "reproducible research" [6] . Indeed, journals increasingly ask the researcher to demonstrate that the results of his manuscript are reproducible. The best way to demonstrate this is to make public together both the computer code used and the datasets (under the restriction of respecting patient privacy, and obtaining informed consent). New tools facilitate this ambition, such as R-Markdown (http://rmarkdown.rstudio.com/), which enables writing notebooks integrating the text of the article with the data and methods of analysis, and making it possible for any reader to redo all tables and figures, and to perform any sensitivity analysis that he or she believes important but was not originally reported by the author.
MEDICAL INFORMATICS

Clinical Microbiology Informatics
Clinical microbiology informatics is a vast domain [7] . Laboratory automation, image analysis, and telemicrobiology usually come with ready-to-use software, manuals, and tutorials that can be used directly by the biologists. By contrast, bioinformatics requires specialized on-site dedicated scientists (bioinformaticians) with an in-depth knowledge of existing databases and of the new tools of sequence analysis.
An important subdomain of clinical microbiology informatics is medical informatics. The definition and use of appropriate standards for data exchange between laboratories and between laboratories and clinics, the choices of terminologies, the workable integration of the different sources of information-in the microbiology laboratory, in the infectious ward, in the rest the hospital (if the patient has or had another pathology than infectious), and outside the hospital-are not simple problems. They have to be handled by specialists (medical informaticians) knowledgeable in infectious diseases.
In many programs, the microbiological data acquired in the institute gain value if they can be linked to public health databases. Examples of such databases are, in France, the death certificates database (CepiDC) and the French social security system database (SNIIRAM, which collects data from 1.2 billion care sheets per year). This implies a staff with informaticians able to match the biological samples with the patient information, and an important and time-consuming administrative work (to fulfill the legal and ethical constraints and regulations that guarantee the consent of the patients involved and the confidentiality of their data).
The environmental databases can be of particular interest as they enable, for example, to relate a microorganism with the ecology of a vector or with the past environment of a patient. For example, a geographic information system (GIS) was used to identify the zoonotic origin of community-acquired pneumopathies [8] . More generally, GIS enables the discovery of the time-space signature of an epidemic, which is information still lacking for most infectious diseases (it has been noted that of the 174 infectious diseases that have a strong rationale for mapping, only 7 had been comprehensively mapped) [9] .
Knowledge Representation
"Knowledge" has been described by information scientists as "data plus interpretation of the data" [10] . The data are booming, and in parallel, the possible interpretations of the data. This explains the importance taken by the field of "knowledge management" whose first task is knowledge representation (what is, for example, the best way to abstract the characteristics of a collection of microorganisms?). A series of subspecialties in informatics tackles this problem, such as the semantic web and ontologies. An ontology is a representation of a domain that fully describes its components (objects and concepts), the individual properties of theses components, and the relationships that link them together. Unique identifiers that are associated to the objects and concepts of the domain can then be used to query molecular databases, and bioontologies serve to describe complex biological features [11] . Examples of ontologies in the field of microbiology are the agriculture-oriented microbial taxonomy ontology [12] and the Antibiotic Resistance Ontology, which is at the base of the Comprehensive Antibiotic Resistance Database [13] .
It is inconceivable that a laboratory of microbiology would constitute a collection of microorganisms using state-of-the-art biological tools, but would lack at the end the computer science expertise to derive the proper representation needed to further classify them, retrieve them, and update the relevant global databases. On the flip side, how can the most gifted computer scientist build the "knowledge representation" of a domain in infectious diseases without a close, daily, interaction with the biologists? This is why, in this critical domain as well, the computer scientists in charge of knowledge representation must be fully integrated in the institute of infectious diseases.
Knowledge Discovery
One step beyond knowledge representation is the domain of knowledge discovery. Here, the final ambition is that of artificial intelligence resources applied to the systematic analysis of existing data and publications being used to make discoveries in biology. Is that totally unrealistic? Think to automatic translation from language A to language B: In the recent past, the approach was to model the grammars of language A and B, and try to map one on the other. It did not work well. Now, everybody can find online good automatic translations of texts in almost any existing language on Earth. This was achieved by the combination of 3 features: (1) the collection of a huge number of translated texts that provided the "training samples"; (2) the use of machine learning algorithms trained on these already translated texts, and then used to search close similarities with the text to translate; and (3) the power and speed of the computers that increased dramatically over the last decade. This enabled, for example, the use of artificial neural networks that were described long ago, in the 1980s, but could not at that time be implemented at a sufficient size and speed on the existing computers. Is it impossible to anticipate that the same kind of approaches will be used to infer the best possible treatment for a patient from the analyses of millions of life trajectories where biology, genetics, imaging, environment, treatments, and outcomes will be available? Or that the automatic analysis of thousands of publications will make results emerge that were not seen with the human eyes and brains of the few (if any) researchers that read them all? The Knowledge Integration Toolkit (KnIT) is an example of a prototype knowledge discovery tool that was developed by IBM and the Baylor College of Medicine. The authors gave a proof of concept with the example of the tumor suppressor P53 for which some 70 000 articles were published (up to now 50 000 000 articles have been published); by mining the whole literature with their tool, they could automatically find new protein kinases phosphorylating p53 [14] .
DATA SCIENCE IN EPIDEMIOLOGY OF INFECTIOUS DISEASES
Clinical and Population Epidemiology
An institute of infectious diseases located in a university hospital necessarily has clinical epidemiology and population epidemiology research programs. In clinical epidemiology, defined as the epidemiology done at the bed of the inpatient, this institute has vocation to be the local leader for hospital infection control programs, and for the design and conduct of clinical trials of treatments against infectious diseases. Often, other projects arise in collaboration with other disciplinesfor example to search infectious cofactors in the etiology or prognosis of noninfectious diseases. The lead and the conduct of these projects depend on the specific organization of the hospital.
Because the microbiology laboratory diagnoses thousands of specimens coming from inside and outside the hospital, there is a great temptation to do population epidemiology grafted on these data treasures. However, a mass of data, samples, and patients does not make an epidemiological program. In epidemiological designs, data are acquired along a timeline, from cause to effect (cohort) or from effect to cause (case-control). A huge collection of patients for which one blood sample has been tested has in general little epidemiological value, as the time factor is lacking. All efforts must be devoted to construct real cohorts with a sufficient follow-up, guarantees of absence of missing follow-ups, and high data quality for the microbiological values and for the clinical endpoints. A staff with competences in epidemiological design, data curation, biostatistics, medical, population, and environmental information systems is necessary to give the proper epidemiological answer to the questions posed by the infectious diseases community.
Mathematical Modeling of Epidemics
The more visible part of mathematical models of epidemics [15] by the public is their use to predict the future sizes of emerging, or remerging, diseases. It was used for AIDS, prion diseases, influenza pandemics, Ebola, and so forth. Some of these predictions were later verified; others were contradicted by the facts. However, the important uses of mathematical modeling are rather to estimate disease parameters that are not accessible to direct observation (eg, incubation time, latent and infectious periods) and to test in silico hypothetical mitigation strategies of epidemics under well-specified hypotheses. Mathematical modeling of epidemics relies on a variety of data sometimes coming from outside the biomedical field (eg, sociologists to characterize the interactions within and between populations, anthropologists, social media specialists [16] ). Mathematical modeling of epidemics has become a scientific domain by itself, with specialized journal and conferences (Epidemics). An infectious diseases university hospital may therefore choose to rely on external collaborations, rather than building its own group of critical size. Its role will then be to provide to the modeler expertise and data to build the models: For example, it has been shown, quite expectedly, that a key model parameter for the control of an infectious disease was the proportion of presymptomatic (or asymptomatic) transmission [17] . This necessitates a careful microbiological and clinical follow-up of cohorts of newly infected subjects, which can only be done in institutes of infectious diseases. The recent Ebola outbreaks remind us how difficult (and important) it can be to get a precise quantitative image of the natural history of emergent/reemergent infectious diseases.
CONCLUSIONS
The central message of this article is that biostatisticians, epidemiologists, and computer scientists must be integrated with microbiologists and clinicians to effectively fight infectious diseases. This is because the "big data" era inextricably mixes data, knowledge, and support to action. It looks impossible to model the knowledge in infectious diseases without being in situ, working hand in hand with the experimentalists and all those who work to discover new pathogens and treatments. Then, the computing personnel must also be real researchers in their field, not just excellent technicians. This is because the methods and the algorithms that will aid discovery in infectious diseases are perpetually evolving and may well be those algorithms that presently succeed in linguistics, or in a remote domain. A dialogue is 2-way: reversely, biologists and physicians of the institute must be computer literate; this means efforts to train them when they are students and, later, in continuing education programs.
Finally, it cannot be denied that all the numerous tasks and subspecialities identified in this article call for a vibrant workforce. At the moment of hiring the best data scientists to serve the cause of the fight of infectious diseases, a serious difficulty to be accounted for is competition with the private sector, which is well aware of the priorities listed in this article and offers much higher salaries to these specialists than public institutions can do. The hope is that the cause of fighting infectious diseases will be sufficiently attractive to overcome this difficulty. 
